Results 101 to 110 of about 10,142,751 (308)

Overall and disease-free survival.

, 2014
Kaplan-Meier survival analysis (log-rank test) depending on CEACAM 1, 5 and 6 expression in immunohistochemistry (IHC) and serum samples (ELISA) for patients with pancreatic ductal adenocarcinoma.Overall and disease-free survival.
Jakob R. Izbicki (302620), Florian Gebauer (318647), Jennifer Horst (698077), Udo Schumacher (149148), Michael Tachezy (318639), Hanna Maar (698079), Maximilian Bockhorn (318648), Daniel Wicklein (333203), Philipp Sundermann (698078), Thomas Streichert (32930)   +9 more
core   +1 more source

Prolonged survival of patients receiving trastuzumab beyond disease progression for HER2 overexpressing metastatic breast cancer (MBC) [PDF]

, 2005
Background: The aim of this retrospective analysis was to evaluate the impact of trastuzumab-based regimens on the survival of patients with HER2-overexpressing metastatic breast cancer (MBC).
Heinrich, B., Stemmler, H. J., Kahlert, S., Heinemann, Volker, Siekiera, W., Untch, M.   +5 more
core   +1 more source

Hijacking emergency granulopoiesis: Neutrophil ontogeny and reprogramming in cancer

Molecular Oncology, EarlyView.
Neutrophils are highly plastic innate immune cells; their functions in cancer extend beyond the tumour microenvironment. This Review summarises current understanding of neutrophil maturation and heterogeneity and highlights tumour‐induced granulopoiesis as a systemic programme that expands immature, immunosuppressive neutrophils via tumour‐derived ...
Gabriela Marinescu, Yi Feng
wiley   +1 more source

Transcriptional profiling of circulating extracellular vesicles from prebiopsy prostate cancer patients

Molecular Oncology, EarlyView.
RNA profiling of circulating extracellular vesicles (EVs) from blood samples of men undergoing prostate biopsy identifies transcripts associated with clinically significant prostate cancer. Integrative analysis with public tumor datasets links EV‐derived gene signatures to tumor stage and progression‐free survival, highlighting CASP3, XRCC2, and RIT1 ...
Stefan Werner, Pierre Tennstedt, Randi C. Pose, Christian Müller, Katharina Besler, Svenja Schneegans, Malik Alawi, Marie C. Roesch, Sven Peine, Desiree Bonci, Joanna Budna‐Tukan, Evi Lianidou, Catherine Alix‐Panabières, Derya Tilki, Klaus Pantel   +14 more
wiley   +1 more source

Survival Outcome of Patients with Vaginal Malignancy: A 10-year Cohort Study from Tertiary Care Centre, Southern India

Journal of Clinical and Diagnostic Research
Introduction: Vaginal malignancy is a rare gynaecological malignancy, and authors know little about its survival and prognostic factors. The management of vaginal malignancies is largely determined by factors such as histological type, tumor size ...
Ramani Gangadharan Ashitha, Adarsh Dharmarajan, Geetha Muttath, PP Hiba   +3 more
doaj   +1 more source

Diabetes mellitus and poorer prognosis in hepatocellular carcinoma: a systematic review and meta-analysis.

PLoS ONE, 2014
BackgroundPrevious studies suggested that diabetes mellitus was associated with cancer risk and prognosis, but studies investigating the relationship between diabetes mellitus and survival in patients with hepatocellular carcinoma (HCC) reported ...
Yan-Gang Wang, Peng Wang, Bin Wang, Zheng-Ju Fu, Wen-Juan Zhao, Sheng-Li Yan   +5 more
doaj   +1 more source

Disease-free survival at 2 and 3 years is a significant early surrogate marker predicting the 5-year overall survival in patients treated with radical cystectomy for urothelial carcinoma of the bladder: external evaluation and validation in a cohort of Korean patients

Frontiers in Oncology, 2015
Purpose: We aimed to externally validate the association of 2- and 3-year disease-free survival with 5-year overall survival in patients treated with radical cystectomy for urothelial carcinoma of the bladder.
Hyung Suk eKim, Chang Wook eJeong, Cheol eKwak, Hyeon Hoe eKim, Ja Hyeon eKu   +4 more
doaj   +1 more source

Survival and disease-free survival analyses in the combined cohort.

, 2020
The survival curve (a) and disease-free survival (b) were calculated for the combined cohort according to the miRNA signature by Kaplan-Meier and log-rank.
Taiyuan Li (8442702), Jinzhong Duanmu (8442699), Yunxia Lv (810158), Qunguang Jiang (8442705), Xiaorui Fu (5495570)   +4 more
core   +1 more source

Metastasis on pause: How dormant tumor cells stay hidden within the tumor microenvironment and evade immune surveillance

Molecular Oncology, EarlyView.
Dormant cancer cells can hide in distant organs for years, evading treatment and the immune system. This review highlights how signals from the surrounding tissue and immune environment keep these cells inactive or trigger their reawakening. Understanding these mechanisms may help develop therapies to eliminate or control dormant cells and prevent ...
Kanishka Tiwary, Jose Javier Bravo‐Cordero   +1 more
wiley   +1 more source

Univariate analysis for disease-free survival and overall survival.

, 2015
Univariate analysis for disease-free survival and overall survival.
Huanwen Wu (697595), Liang Zhu (172992), Huadan Xue (487099), Wenze Wang (586963), Xiaohua Shi (697596), Li Zhang (8200), Hui Zhang (7197), Zhiyong Liang (580570)   +7 more
core   +1 more source